Teva Pharmaceutical Under Fire For Sale Of Dangerous Drug

The world's largest generic drug manufacturer, Teva Pharmaceutical Industries, is facing over 300 lawsuits resulting from a 2007 Hepatitis C outbreak. Plaintiffs allege that the company packaged the anesthetic propofol in a manner that contributed to the spread of the incurable liver disease.

The outbreak occurred when doctors at a Nevada endoscopy clinic used 50 milliliter vials of propofol to administer doses of the anesthetic to multiple patients. Although the vials were marked "single use only," it is alleged that the company knew the vials' large size would lead to multiple uses. Further, it is being argued that the company knew that multiple uses could lead to the vials becoming contaminated, even if doctors used a clean syringe each time.

The lawsuits allege that propofol's misleading packaging qualified it as a dangerous drug under products liability law. Further, they allege that Teva was negligent in failing to adequately warn doctors of the dangers of using a single vial to administer multiple doses.

Victims believe their case is buoyed by evidence showing that the company understood the dangers posed by its product years before the outbreak, yet did little to remedy the situation. They allege that evidence shows that in 2000, Teva asked the U.S. Food and Drug Administration for permission to sell the drug in a 10 milliliter vial because the size was closer to a single-patient dose and would reduce the temptation to give multiple patients injections from the same container.

However, Teva allegedly changed its outlook when it discovered that it could produce the 10 and 50 milliliter vials at the same speed. The company realized that if it switched its focus to the large size, it could generate five times more profit, it is alleged.

JURIES AWARDING SUBSTANTIAL VERDICTS

So far, the company has already settled nearly half the cases brought against it. This may be because the cases that have gone to trial have resulted in very large jury verdicts. In one case, a jury awarded a private-school principal who had been infected with Hepatitis C $5.1 million in compensatory damages and $500 million in punitive damages. In another case, a former air force pilot recovered a $104 million verdict, including $60 million in punitive damages against Teva.

Although jury verdicts vary greatly from case to case, these awards are in line with the substantial nature of Teva's negligence and the severity of the plaintiffs' injuries.

If you or a loved one has been harmed by a dangerous drug, contact an experienced product liability attorney who can help you protect your rights.

Categories

    Attorney Tor and the whole team at Spangenberg Shibley & Liber, including the receptionist, made me feel welcome, comforted, and confident throughout my case. They showed me respect and kindness from start to finish.

    - Zandra S.

    I was feeling uncertain but after I met with Nick I felt at ease & confident. Communication was great, I was constantly informed and everyone was genuine & compassionate.

    - Sonja S.

    Coming in, we were unsure if we had a case. After meeting with Peter Brodhead, we were very confident with him. I was always comfortable because everyone was professional and friendly.

    - Elaine B.

    I liked the professionalism, efficiency, and thoroughness of your team efforts. I would like Sheila Schebek recognized for her knowledge of account details as quickly as I presented questions. She provided confidence and security in all matters.

    - John S.

    Before I called you, I felt awful & depressed when I heard about cancer. After I called you and discussed, I felt better knowing that this law firm cared for me. They were very kind and well communicated with me.

    - Gary S.
/

Put Award-Winning
Trial Lawyers On Your Side

Contact Our Team for a Free & Confidential Case Evaluation
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.